Clinical Trial Update: Chronic Graft-versus-host Disease (cGvHD) Prophylaxis With or Without ATG Prior to Stem Cell Transplantation (SCT) From HLA-identical Siblings in Patients With Acute Leukemia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating prophylaxis for chronic graft-versus-host disease using anti-thymocyte globulin (ATG) prior to stem cell transplantation from HLA-ident…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia

Drugs mentioned

• ATG (anti-thymocyte globulin) (anti-thymocyte globulin)

Snippet

Sponsor: Universitätsklinikum Hamburg-Eppendorf | Conditions: Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia | Phase 3 | Status: COMPLETED